Tokio Marine Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,200
Closed -$252K 512
2022
Q2
$252K Buy
8,200
+600
+8% +$17.5K 0.02% 421
2022
Q1
$245K Sell
7,600
-1,800
-19% -$47.1K 0.02% 430
2021
Q4
$260K Sell
9,400
-5,800
-38% -$166K 0.02% 423
2021
Q3
$471K Sell
15,200
-1,000
-6% -$24K 0.04% 247
2021
Q2
$342K Sell
16,200
-1,400
-8% -$28K 0.03% 287
2021
Q1
$356K Sell
17,600
-6,100
-26% -$116K 0.04% 243
2020
Q4
$380K Buy
23,700
+2,600
+12% +$34.4K 0.04% 201
2020
Q3
$262K Buy
+21,100
New +$248K 0.03% 238

Other funds holding EVH

Tokio Marine Asset Management's EVH Position: Q3 2022 in Review

Tokio Marine Asset Management sold out of Evolent Health (EVH) in Q3 2022, closing a stake of 8,200 shares — an estimated $252K sold.

Tokio Marine Asset Management first reported a position in EVH in Q3 2020 and held it in 8 quarters. The position peaked at $471K in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

  • Tokio Marine Asset Management reported no remaining Evolent Health position as of Q3 2022 after selling out during the quarter.
  • Tokio Marine Asset Management sold 8,200 Evolent Health shares in Q3 2022, an estimated $252K.
  • Tokio Marine Asset Management first reported a position in Evolent Health in Q3 2020 and held it in 8 quarters.
  • Tokio Marine Asset Management's Evolent Health position peaked at $471K in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on Tokio Marine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.